G 2/21: how to support inventive steps in patentability

Post-published evidence can be crucial to establishing patentability. G 2/21, the European Patent Office (EPO)’s referral to the Enlarged Board of Appeal (EBA) on the question of whether post-published evidence can be used to support the concept of “inventive step”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Pharma

Mylan throws down new gauntlet in Novo Wegovy patent fight

25 September 2026 Another Wegovy patent has been drawn into the long-running dispute between Mylan and Novo Nordisk over proposed generic versions of the weight-loss drug.

Pharma

Novartis defeats Orange Book challenge but suffers EU setback

24 September 2026 An Entresto Orange Book listing has survived a challenge in the US, while two trademark disputes handed Novartis contrasting fortunes at a European court.

Careers

New UK High Court judge named as replacement for Justice Meade

23 September 2026 Following the prominent patent judge’s promotion to the Court of Appeal, the judiciary has appointed a King’s Counsel with 35 years’ experience as a barrister.

More features

Beyond the primary patent: How pharma can build competitive barriers

Patent lawyers and judges discuss lofty UPC issues in grand London venue

Abbott clinches 18-country PI in glucose monitoring feud

G 1/25: EPO settles controversial patent description question

Abbott fends off Chinese rival’s patent challenge at UPC

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

The UPC plugs another gap in its procedural rulebook

G 2/21: how to support inventive steps in patentability

More on this story

Editor's picks

Editor's picks

More features